Heretumoros betegek termékenyítőképességének vizsgálata

Martin, Tamás ✉; Dank, Magdolna [Dank, Magdolna (onkológia), author] Onkológiai Központ (SU / FM / C); Biró, Krisztina [Bíró, Krisztina (Orvostudomány), author] National Institute of Oncology; Küronya, Zsófia [Küronya, Zsófia (klinikai onkológia), author] National Institute of Oncology; Gyergyay, Fruzsina [Gyergyay, Fruzsina (Onkológia), author]; Nagyiványi, Krisztián [Nagyiványi, Krisztián András (Klinikai onkológiai), author] National Institute of Oncology; Budai, Barna [Budai, Barna (Onkológia), author] National Institute of Oncology; Fűrész, Katinka; Géczi, Lajos [Géczi, Lajos (Onkológia), author] National Institute of Oncology

Hungarian Article (Journal Article) Scientific
Published: MAGYAR ONKOLÓGIA 0025-0244 2060-0399 65 (1) pp. 53-57 2021
  • SJR Scopus - Medicine (miscellaneous): Q4
Identifiers
Subjects:
  • Clinical medicine
Germ cell tumors of the testicle account for 1% of all tumors. Testicular cancer (TC) is the most common malignancy in men aged 15-35 years. Patients with TC have an excellent survival rate but often have not yet attempted to father children, and fertility is one of the main concerns of survivors, therefore it is important to preserve it. The most commonly used method is sperm banking. Retrospective analysis of the Hungarian data showed that in case of testicular cancer spermatogenesis is more impaired in the more advanced disease. No correlation was found among the histological types and the proportion of azoo- and oligozoospermia. The parameters of testicular cancer and non-Hodgkin lymphoma patients were worse compared to the normal population. Sperm cryopreservation prior to initiating life-saving cancer treatment offers men the best chance to father children and should be offered to all men with testicular cancer before chemotherapy, since cytostatic therapy may lead to infertility.
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2026-06-11 15:13